Institut De Recherches Internationales Servier
Clinical trials sponsored by Institut De Recherches Internationales Servier, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New pill targets rare gene mutation in Hard-to-Treat blood cancers Results expected Dec 2026 (estimated)
-
Leukemia drug trial halted early: what we know
Disease control Stopped earlyThis study tested a drug called calaspargase pegol in adults aged 22 and older with a specific type of leukemia (Philadelphia-negative ALL). The goal was to find the right dose and check for side effects. The trial was stopped early, but researchers were looking at how the drug w…
Phase 2/3 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New imaging tracks cancer drug in body
Knowledge-focused Stopped earlyThis study used PET scans to track where a new antibody drug (S095012) goes in the body and in tumors of people with advanced solid cancers. Only 3 participants were enrolled before the study was stopped early. The goal was to understand how the drug spreads and targets tumors, n…
Phase 1 • Sponsor: Institut de Recherches Internationales Servier • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC